Clinical Trial Update: Atrial Natriuretic Peptide in Assessing Fluid Status [NA]

View source ↗

Summary

Completed clinical trial assessing atrial natriuretic peptide for evaluating fluid status; results were posted in June 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure

Drugs mentioned

• Atrial natriuretic peptide (atrial natriuretic peptide)

Snippet

Sponsor: Petrovsky National Research Centre of Surgery | Conditions: Fluid Overload, Fluid Loss | NA | Status: COMPLETED | Results posted: 2025-06-08